Marché nord-américain de la gestion des maladies chroniques – Tendances et prévisions du secteur jusqu’en 2028

Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché nord-américain de la gestion des maladies chroniques – Tendances et prévisions du secteur jusqu’en 2028

  • Healthcare
  • Publish Reports
  • Jun 2021
  • North America
  • 350 Pages
  • Nombre de tableaux : 59
  • Nombre de figures : 45

Marché de la gestion des maladies chroniques en Amérique du Nord, par type (solution et services), type de solution (solution sur site, solution basée sur le cloud, solution basée sur le Web), type de service (service éducatif, service de mise en œuvre, service de conseil et autres), indication de maladie (maladies cardiovasculaires (MCV), diabète, bronchopneumopathie chronique obstructive (BPCO), arthrite, asthme, cancer et autres), utilisateur final (prestataires de soins de santé, payeurs de soins de santé, autres), pays (États-Unis, Canada, Mexique) Tendances et prévisions de l'industrie jusqu'en 2028

Marché nord-américain de la gestion des maladies chroniques

Analyse et perspectives du marché : marché nord-américain de la gestion des maladies chroniques

Le marché nord-américain de la gestion des maladies chroniques devrait connaître une croissance du marché au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît avec un TCAC de 15,6 % au cours de la période de prévision de 2021 à 2028 et devrait atteindre 6 764,12 millions USD d'ici 2028. La prévalence croissante des maladies chroniques exige des solutions et des services avancés de gestion des maladies chroniques, ce qui constitue un moteur de la croissance du marché de la gestion des maladies chroniques.

La gestion des maladies chroniques (GMC) consiste en des soins et un soutien continus destinés à aider les personnes touchées par une maladie chronique à obtenir les soins médicaux, les connaissances, les compétences et les ressources dont elles ont besoin pour mieux gérer leur quotidien. Elle est principalement assurée par divers logiciels et services. La gestion des maladies chroniques contribue à réduire les coûts des soins de santé et à améliorer la qualité de vie des personnes atteintes de maladies chroniques en prévenant ou en minimisant les effets de la maladie grâce à des soins intégrés.

L'augmentation de la population gériatrique et la prévalence croissante des maladies chroniques constituent un moteur pour le marché de la gestion des maladies chroniques. Les problèmes de sécurité liés aux solutions basées sur le cloud réduisent la demande de solutions de gestion des maladies chroniques, ce qui freine la croissance du marché de la gestion des maladies chroniques. L'essor des nouvelles avancées technologiques constitue une opportunité pour le marché de la gestion des maladies chroniques. Cependant, le manque d'accessibilité dans les pays à revenu faible et intermédiaire constitue un défi pour la croissance du marché de la gestion des maladies chroniques.

Le rapport sur le marché de la gestion des maladies chroniques en Amérique du Nord fournit des détails sur la part de marché, les nouveaux développements et l'analyse du pipeline de produits, l'impact des acteurs du marché national et local, analyse les opportunités en termes de poches de revenus émergentes, de changements dans la réglementation du marché, d'approbations de produits, de décisions stratégiques, de lancements de produits, d'expansions géographiques et d'innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché de la gestion des maladies chroniques, contactez Data Bridge Market Research pour un briefing d'analyste, notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.

Marché nord-américain de la gestion des maladies chroniques

Portée et taille du marché de la gestion des maladies chroniques

The chronic disease management market is segmented on the based on the type, solution type, service type, disease indication and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the chronic disease management market is segmented into solution and services. In 2021, solution segment is expected to dominate the chronic disease management market due to rising geriatric populace. 
  • On the basis of solution type, the chronic disease management market is segmented into on-premise solution, cloud-based solution and web-based. In 2021, on premise solution vectors segment is expected to dominate the chronic disease management market due to rising adoption on premise solution.
  • On the basis of service type, the chronic disease management market is segmented into education service, implementation service, consulting service and others. In 2021, Implementation Services segment is expected to dominate the chronic disease management market due to rising strategic initiatives by key players. 
  • On the basis of disease indication, the chronic disease management market is segmented into cardiovascular diseases (CVD), diabetes, chronic obstructive pulmonary disorders (COPD), arthritis, asthma, cancer and others. In 2021, cardiovascular diseases (CVD) segment is expected to dominate the chronic disease management market due to rising incidence of chronic diseases. 
  • On the basis of end user, the chronic disease management market is segmented into healthcare providers, healthcare payers, others. In 2021, healthcare providers segment is expected to dominate the chronic disease management market due to rising pace of early diagnosis and screening.

Chronic Disease Management Market Country Level Analysis

The chronic disease management market is analyzed and market size information is provided by the country, type, solution type, service type, disease indication and end user as referenced above.

The countries covered in the North America chronic disease management market report are the U.S., Canada and Mexico.  

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growing Strategic Activities by Major Market Players to Enhance the Awareness for Chronic Disease Management is Boosting the Market Growth of Chronic Disease Management market.

The chronic disease management market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.

Competitive Landscape and Chronic Disease Management Market Share Analysis

Chronic disease management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Chronic Disease Management market.

The major companies which are dealing in the North America chronic disease management are Koninklijke Philips N.V., WellSky, ZeOmega, Health Catalyst, Cedar Gate Technologies, Cognizant, Pegasystems Inc., Epic Systems Corporation, Hinduja Global Solutions Ltd., NXGN Management, LLC, MINES & Associates, Inc., Casenet, LLC, ExlServings Holdings, Inc., cliexa, Inc., ScienceSoft USA Corporation, Vivify Health, Inc., Allscripts Healthcare, LLC., Infosys Limited, Medecision, IBM corporation, Altruista Health and TCS Healthcare Technologies among others domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the North America chronic disease management market.

For instance,

  • In April 2021, WellSky launched advanced home health visit management solution. The new addition CareInsights Guidance provides actionable visit utilization insights to balance the care quality and patient health improvement. It is predicted that, this solution launch will provide benefits to their patients, staff, and leading to upsurge the sales growth of the company.
  • In December 2020, HGS AxisPoint Health (a subsidiary of Hinduja Global Solutions Ltd.), partnered with Parkland Community Health Plan (PCHP). The primary purpose of this partnership was to supply disease management services to approximately 195,000 Medicaid beneficiaries in North Texas. This enhanced the company’s presence in global market, leading to upsurge the sales growth of the company.

La collaboration, le lancement de produits, l'expansion commerciale, les récompenses et la reconnaissance, les coentreprises et d'autres stratégies des acteurs du marché améliorent l'empreinte de l'entreprise sur le marché de la gestion des maladies chroniques, ce qui offre également l'avantage de la croissance des bénéfices de l'organisation.


SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET END USER COVERAGE GRID

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: REGULATIONS

5.1 REGULATION IN THE UNITED STATES:

5.2 GOVERNING REGULATIONS:

5.3 CPT CODES:

5.4 PRACTITIONER ELIGIBILITY:

5.5 PATIENT ELIGIBILITY:

5.6 REQUIREMENTS:

5.7 REGULATIONS IN EUROPE:

5.8 NATIONAL STRATEGY AND LEAD ORGANIZATIONS FOR HEALTHCARE SERVICES IN EUROPE:

5.9 DATA PRIVACY PROTECTION IN EUROPE:

5.1 REGULATIONS IN INDIA:

5.11 RELEVANT ACTS FOR THIS FRAMEWORK:

5.12 DATA PRIVACY PROTECTION IN INDIA:

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES

6.1.2 GROWING GERIATRIC POPULATION

6.1.3 RISING PER CAPITA INCOME

6.1.4 ADVANCEMENT IN HEALTHCARE INFRASTRUCTURE AND INITIATIVE ACTIVITIES BY GOVERNMENT ORGANIZATION

6.2 RESTRAINTS

6.2.1 HIGH COST OF SERVICES

6.2.2 SECURITY CONCERNS WITH CLOUD-BASED SOLUTIONS

6.3 OPPORTUNITIES

6.3.1 SURGE IN NOVEL TECHNOLOGICAL ADVANCEMENTS

6.3.2 RISING HEALTHCARE EXPENDITURE

6.3.3 INCREASED REIMBURSEMENT POLICIES

6.3.4 RISING DISEASE MANAGEMENT PROGRAMS

6.4 CHALLENGE

6.4.1 LACK OF ACCESSIBILITY

7 IMPACT OF COVID-19 ON THE NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET

7.1 IMPACT ON PRICE

7.2 IMPACT ON DEMAND

7.3 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS

7.4 CONCLUSION

8 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE

8.1 OVERVIEW

8.2 SOLUTION

8.3 SERVICES

9 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE

9.1 OVERVIEW

9.2 ON PREMISE SOLUTION

9.3 WEB BASED SOLUTION

9.4 CLOUD BASED SOLUTION

10 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICES TYPE

10.1 OVERVIEW

10.2 IMPLEMENTATION SERVICES

10.3 CONSULTING SERVICES

10.4 EDUCATION SERVICES

10.5 OTHERS

11 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION

11.1 OVERVIEW

11.2 CARDIOVASCULAR DISEASES (CVD)

11.3 DIABETES

11.4 CHRONIC OBSTRUCTIVE PULMONARY DISORDERS (COPD)

11.5 ASTHMA

11.6 ARTHRITIS

11.7 CANCER

11.8 OTHERS

12 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER

12.1 OVERVIEW

12.2 HEALTHCARE PROVIDERS

12.2.1 HOSPITALS, PHYSICIAN GROUPS, INTEGRATED DELIVERY

12.2.2 DIAGNOSTIC & IMAGING CENTERS

12.2.3 AMBULATORY CARE CENTERS

12.2.4 HOME HEALTHCARE AGENCIES, NURSING HOMES & ASSISTED LIVING FACILITIES

12.2.5 OTHERS

12.3 HEALTHCARE PAYERS

12.3.1 PUBLIC PAYERS

12.3.2 PRIVATE PAYERS

12.4 OTHERS

13 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET BY REGION

13.1 NORTH AMERICA

13.1.1 U.S.

13.1.2 CANADA

13.1.3 MEXICO

14 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

15 SWOT ANALYSIS

16 COMPANY PROFILES

16.1 IBM CORPORATION

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 SERVICE PORTFOLIO

16.1.5 RECENT DEVELOPMENTS

16.2 KONINKLIJKE PHILIPS N.V.

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENTS

16.3 COGNIZANT

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENTS

16.4 ALLSCRIPTS HEALTHCARE, LLC

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 SOLUTION PORTFOLIO

16.4.5 RECENT DEVELOPMENTS

16.5 ALTRUISTA HEALTH

16.5.1 COMPANY SNAPSHOT

16.5.2 SOLUTION PORTFOLIO

16.5.3 RECENT DEVELOPMENTS

16.6 CASENET, LLC

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT & SERVICE PORTFOLIO

16.6.3 RECENT DEVELOPMENTS

16.7 CEDAR GATE TECHNOLOGIES

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENT

16.8 CLIEXA, INC.

16.8.1 COMPANY SNAPSHOT

16.8.2 SOLUTION PORTFOLIO

16.8.3 RECENT DEVELOPMENTS

16.9 EPIC SYSTEMS CORPORATION

16.9.1 COMPANY SNAPSHOT

16.9.2 SERVICE PORTFOLIO

16.9.3 RECENT DEVELOPMENT

16.1 EXLSERVICE HOLDINGS, INC.

16.10.1 COMPANY SNAPSHOT

16.10.2 REVENUE ANALYSIS

16.10.3 SERVICE PORTFOLIO

16.10.4 RECENT DEVELOPMENTS

16.11 HEALTH CATALYST

16.11.1 COMPANY SNAPSHOT

16.11.2 REVENUE ANALYSIS

16.11.3 PRODUCT PORTFOLIO

16.11.4 RECENT DEVELOPMENT

16.12 HINDUJA NORTH AMERICA SOLUTIONS LTD.

16.12.1 COMPANY SNAPSHOT

16.12.2 REVENUE ANALYSIS

16.12.3 PRODUCT PORTFOLIO

16.12.4 RECENT DEVELOPMENTS

16.13 INFOSYS LIMITED

16.13.1 COMPANY SNAPSHOT

16.13.2 REVENUE ANALYSIS

16.13.3 SOLUTION PORTFOLIO

16.13.4 RECENT DEVELOPMENTS

16.14 MEDECISION

16.14.1 COMPANY SNAPSHOT

16.14.2 SOLUTION PORTFOLIO

16.14.3 RECENT DEVELOPMENT

16.15 MINES & ASSOCIATES, INC.

16.15.1 COMPANY SNAPSHOT

16.15.2 PRODUCT PORTFOLIO

16.15.3 RECENT DEVELOPMENT

16.16 NXGN MANAGEMENT, LLC

16.16.1 COMPANY SNAPSHOT

16.16.2 REVENUE ANALYSIS

16.16.3 PRODUCT PORTFOLIO

16.16.4 RECENT DEVELOPMENTS

16.17 PEGASYSTEMS INC.

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 SCIENCESOFT USA CORPORATION

16.18.1 COMPANY SNAPSHOT

16.18.2 INDUSTRY PORTFOLIO

16.18.3 RECENT DEVELOPMENTS

16.19 TCS HEALTHCARE TECHNOLOGIES

16.19.1 COMPANY SNAPSHOT

16.19.2 SERVICE PORTFOLIO

16.19.3 RECENT DEVELOPMENTS

16.2 VIVIFY HEALTH, INC.

16.20.1 COMPANY SNAPSHOT

16.20.2 SOLUTION PORTFOLIO

16.20.3 RECENT DEVELOPMENTS

16.21 WELLSKY

16.21.1 COMPANY SNAPSHOT

16.21.2 PRODUCT PORTFOLIO

16.21.3 RECENT DEVELOPMENTS

16.22 ZEOMEGA

16.22.1 COMPANY SNAPSHOT

16.22.2 PRODUCT PORTFOLIO

16.22.3 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

Liste des tableaux

TABLE 1 NUMBER OF PEOPLE WITH DIABETES AMONG 20–79 YEARS OLD (IN MILLION)

TABLE 2 NEW CANCER CASES FOR AGE 85+ IN THE U.S.

TABLE 3 PER CAPITA AMOUNTS: THE UNITED STATES (1960–2017)

TABLE 4 PRICES OF ESSENTIAL CHRONIC DISEASE MANAGEMENT SOLUTIONS

TABLE 5 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 6 NORTH AMERICA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 NORTH AMERICA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 9 NORTH AMERICA ON PREMISE SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 NORTH AMERICA WEB BASED SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 NORTH AMERICA CLOUD BASED SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICES TYPE, 2019-2028 (USD MILLION)

TABLE 13 NORTH AMERICA IMPLEMENTATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 NORTH AMERICA CONSULTING SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 NORTH AMERICA EDUCATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 NORTH AMERICA EDUCATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 18 NORTH AMERICA CARDIOVASCULAR DISEASES (CVD) IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 NORTH AMERICA DIABETES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION 2019-2028 (USD MILLION)

TABLE 20 NORTH AMERICA CHRONIC OBSTRUCTIVE PULMONARY DISORDERS (COPD) IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 NORTH AMERICA ASTHMA IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 NORTH AMERICA ARTHRITIS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 NORTH AMERICA CANCER IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 NORTH AMERICA OTHERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 26 NORTH AMERICA HEALTHCARE ROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 NORTH AMERICA HEALTHCARE ROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 28 NORTH AMERICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 NORTH AMERICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 30 NORTH AMERICA OTHERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 32 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 33 NORTH AMERICA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 34 NORTH AMERICA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 35 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 36 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 37 NORTH AMERICA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 38 NORTH AMERICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 39 U.S. CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 40 U.S. SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 41 U.S. SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 42 U.S. CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 43 U.S. CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 44 U.S. HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 45 U.S. HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 46 CANADA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 47 CANADA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 48 CANADA SERVICE TYPE IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 49 CANADA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 50 CANADA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 51 CANADA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 52 CANADA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 53 MEXICO CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 54 MEXICO SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)

TABLE 55 MEXICO SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 56 MEXICO CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)

TABLE 57 MEXICO CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 58 MEXICO HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 59 MEXICO HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

Liste des figures

FIGURE 1 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: MULTIVARIATE MODELLING

FIGURE 7 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: MARKET END USER COVERAGE GRID

FIGURE 11 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION

FIGURE 12 GROWING GERIATRIC POPULATION IS EXPECTED TO DRIVE THE NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 SOLUTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET IN 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET

FIGURE 15 PREVALENCE OF CHRONIC DISEASES

FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLIONS)

FIGURE 17 NORTH AMERICA AGING POPULATION (IN MILLIONS)

FIGURE 18 EUROPE AGING POPULATION (IN MILLIONS)

FIGURE 19 ASIA-PACIFIC AGING POPULATION (IN MILLIONS)

FIGURE 20 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, 2020

FIGURE 21 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, 2019-2028 (USD MILLION)

FIGURE 22 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, CAGR (2021-2028)

FIGURE 23 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 24 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, 2020

FIGURE 25 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, 2019-2028 (USD MILLION)

FIGURE 26 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, CAGR (2021-2028)

FIGURE 27 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, LIFELINE CURVE

FIGURE 28 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, 2020

FIGURE 29 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, 2019-2028 (USD MILLION)

FIGURE 30 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, CAGR (2021-2028)

FIGURE 31 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, LIFELINE CURVE

FIGURE 32 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, 2020

FIGURE 33 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, 2019-2028 (USD MILLION)

FIGURE 34 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, CAGR (2021-2028)

FIGURE 35 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, LIFELINE CURVE

FIGURE 36 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, 2020

FIGURE 37 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, 2019-2028 (USD MILLION)

FIGURE 38 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, CAGR (2021-2028)

FIGURE 39 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, LIFELINE CURVE

FIGURE 40 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: SNAPSHOT (2020)

FIGURE 41 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2020)

FIGURE 42 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 43 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 44 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE (2021-2028)

FIGURE 45 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY SHARE 2020 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

The North America Chronic Disease Management Market size will be worth USD 6,764.12 million by 2028.
The North America Chronic Disease Management Market growth rate will be 15.6% by 2028.
The Rising prevalence of chronic diseases demands the advanced chronic disease management solutions and services are the growth drivers of the North America Chronic Disease Management Market.
The type, solution type, service type, disease indication and end-user are the factors on which the North America Chronic Disease Management Market research is based.
The major companies in the North America Chronic Disease Management Market are Koninklijke Philips N.V., WellSky, ZeOmega, Health Catalyst, Cedar Gate Technologies, Cognizant, Pegasystems Inc., Epic Systems Corporation, Hinduja Global Solutions Ltd., NXGN Management, LLC, MINES & Associates, Inc., Casenet, LLC, ExlServings Holdings, Inc., cliexa, Inc., ScienceSoft USA Corporation, Vivify Health, Inc., Allscripts Healthcare, LLC., Infosys Limited, Medecision.